ToxStrategies is proud to support the Foundation for Chemistry Research & Initiatives (FCRI) in the important project to comprehensively research the frameworks, metrics,… read more
EpidStrategies’ epidemiologists have collaborated with other researchers on three publications that describe healthcare utilization in 80,000 infants covered by Medicaid, as well as… read more
ToxStrategies is pleased to announce that Dr. Nate Collins has joined our firm as a Senior Consultant. Dr. Collins has 25 years’ experience… read more
ToxStrategies LLC, EpidStrategies, a Division of ToxStrategies LLC, and Modality Solutions are pleased to announce 2024 promotions for nearly three-dozen of our scientists, epidemiologists, statisticians,… read more
ToxStrategies is excited to be attending, exhibiting, and hosting a round table at the World Orphan Drug Congress (WODC), April 23–25, 2024. This… read more
The Food and Drug Administration has released a Final Guidance for Industry to address some ongoing issues with procedures and timing for submitting… read more
ToxStrategies is excited to be attending, presenting, and exhibiting at the Society of Toxicology’s 63rd Annual Meeting and ToxExpo, March 9th 2024, to… read more
HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource use and costs in cardiac arrhythmia patients with paroxysmal supraventricular… read more
